Register  |  Login
Walter LING Dr. Walter Ling is Professor of Psychiatry and the founding director of the Integrated Substance Abuse Programs (ISAP) at UCLA, one of the foremost substance abuse research groups in the US and worldwide. He is board certified in neurology and psychiatry, is active in research and clinical work, and has been listed in ‘Best Doctors in America’, ‘Best Doctors in the West’ and ‘Best Doctors in Los Angeles’. Doctor Ling’s research in opiate pharmacotherapy provided pivotal information for the approval of buprenorphine and naltrexone. His current focus of research includes abuse and dependence on methamphetamine, cocaine, heroin and prescription opiates; opiate induced hyperalgesia, treatment of pain in opiate-maintained patients, including those treated with buprenorphine and the role of buprenorphine in the management of pain in these patients. Dr Ling is a fellow of the American Academy of Neurology He has served as President of the Southern California Physicians Council on Drug Dependence; Commissioner for the Narcotics and Dangerous Drugs Commission, Los Angeles County, California; and a consultant on narcotics for the World Health Organization, the United Nations, and the U.S. Department of State. Dr Ling also serves on the California Society of Addiction Medicine Committee on the Treatment of Opioid Dependence. As Principal Investigator of NIDA’s Clinical Trial Network’s Pacific Region Node, Doctor Ling has extended ISAP’s research beyond the US to China, Southeast Asia and the Middle East.